(Total Views: 492)
Posted On: 08/25/2021 10:08:06 AM
Post# of 145873
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Re: generactor #101516
According to the trial protocol for compassionate use it's 350mg but it's possible they were able to raise the dosage as it was raised in the 2b/3 trial.
There were 9 patients from the phase 2b/3 and 21 from compassionate.
I think the lower numbers are for PFS/OS and the higher numbers are for mOS and mPFS.
There were 9 patients from the phase 2b/3 and 21 from compassionate.
Quote:
This is the part I'm not sure about: Those 22 showed the big increases in the ratio(?) of modified progression-free survival to 12 month progression-free survival and in the ratio of modified overall survival to 12 month modified survival.
I think the lower numbers are for PFS/OS and the higher numbers are for mOS and mPFS.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)